CTSK and coronary artery disorder: While cathepsin K has been associated with progression of unstable plaques and closely associated with CAD [38], galectin-3 has been shown to contribute to macrophage differentiation, foam cell formation, endothelial dysfunction, and vascular smooth muscle cells proliferation and migration [39] in the atheroma and its inhibition might reduce plaque progression [40].